Leprosy cost-effectiveness of therapy
|
Leprosy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Leprosy cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Leprosy cost-effectiveness of therapy |
|
Risk calculators and risk factors for Leprosy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
After the results of the campaign of the WHO to eradicate leprosy, the treatment of this disease may be considered cost-effective.
Cost-effectiveness of Therapy
In 1990, the WHO defined a goal of eliminating leprosy, as a public health issue, within 10 years. Between the years of 1985 and 2010, the number of registered cases of leprosy fell from 5.4 million to 244,796, with prevalence rate per 100,000 falling from 210 to 3.7. These numbers show that with adequate investment in prevention and early treatment of the disease, it is possible to minimize its incidence around the world. Therefore, therapy and research of new and innovative techniques may be considered cost-effective in the case of leprosy. However, there are still endemic regions in the world, where people are suffering the impact of this disease. It it important to invest in the treatment of these populations, in order to fully eradicate leprosy.[1]